DEXMEDETOMIDINE PREVENTS PDIA3 DECREASE BY ACTIVATING &#945;2-ADRENERGIC RECEPTOR TO ALLEVIATE INTESTINAL I/R IN MICE.

Zhan, YaQing; Chen, ZhaoRong; Qiu, YuXin; Deng, Qiwen; Huang, WenQi; Wen, ShiHong; Shen, JianTong

DEXMEDETOMIDINE PREVENTS PDIA3 DECREASE BY ACTIVATING α2-ADRENERGIC RECEPTOR TO ALLEVIATE INTESTINAL I/R IN MICE.

Zhan, YaQing; Chen, ZhaoRong; Qiu, YuXin; Deng, Qiwen; Huang, WenQi; Wen, ShiHong; Shen, JianTong.

Affiliation

Zhan Y; Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Shock ; 58(6): 556-564, 2022 12 01.

Article in En | MEDLINE | ID: mdl-36374735

Subject(s)

Dexmedetomidine; Animals; Mice; Dexmedetomidine/pharmacology; Dexmedetomidine/therapeutic use; Adrenergic alpha-2 Receptor Agonists/pharmacology; Adrenergic alpha-2 Receptor Agonists/therapeutic use; Receptors, Adrenergic, alpha-2/genetics; Receptors, Adrenergic, alpha-2/metabolism; Protein Disulfide-Isomerases/genetics; Protein Disulfide-Isomerases/pharmacology; Mice, Inbred C57BL; Apoptosis; Yohimbine/pharmacology; Inflammation/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dexmedetomidine Limits: Animals Language: En Journal: Shock Year: 2022 Document type: Article

Fulltext

XML

PubMed Links

Search on Google